| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |